"Located in Idaho Falls, Idaho, Rocky Mountain Clinical Research is highly esteemed by producers of medications, insulin pumps and other modalities related to diabetes. We are highly sought after for our clinical research expertise. We are an integral member of a family of medical companies including Rocky Mountain Diabetes Center , Express Lab, and Rocky Mountain Pharmacy. As part of Rocky Mountain Diabetes Center, clinical research has been a big part of our practice for more than 20 years. We have collaborated with most of the major pharmaceutical companies in bringing to market new treatments and medications for diabetes. We have 3 physicians with extensive training and experience overseeing hundreds of clinical trials over 30 years."

During the past decade, Rocky Mountain Clinical Research conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 4 clinical trials were completed, i.e. on average, 13.8% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 4 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rocky Mountain Clinical Research" #1 sponsor was "Eli Lilly and Company" with 21 trials, followed by "DexCom, Inc." with 2 trials sponsored, "CPEX Pharmaceuticals Inc." with 1 trials sponsored, "Mannkind Corporation" with 1 trials sponsored and "Medtronic Diabetes" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain Clinical Research" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Jaeb Center for Health Research" with 1 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator and "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Rocky Mountain Clinical Research" are "Type 2 Diabetes" (7 trials), "Obesity" (5 trials), "Diabetic Peripheral Neuropathic Pain" (3 trials), "Overweight" (3 trials) and "Diabetes" (2 trials). Many other conditions were trialed in "Rocky Mountain Clinical Research" in a lesser frequency.

Most popular intervention types in "Rocky Mountain Clinical Research" are "Drug" (24 trials), "Device" (4 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Tirzepatide" (6 trials), "Insulin Degludec" (4 trials), "Insulin Efsitora Alfa" (3 trials) and "Dulaglutide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rocky Mountain Clinical Research" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Rocky Mountain Clinical Research". undefined are not yet recruiting, 6 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Rocky Mountain Clinical Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Rocky Mountain Clinical Research, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".